Justification for the use of statins in primary prevention : An intervention trial evaluating rosuvastatin (JUPITER)- Can C-reactive protein be used to target statin therapy in primary prevention?MORA, Samia; RIDKER, Paul M.The American journal of cardiology. 2006, Vol 97, Num 2A, issn 0002-9149, 33A-41A, SUPConference Paper

Inflammatory Biomarkers and Risks of Myocardial Infarction, Stroke, Diabetes, and Total Mortality : Implications for LongevityRIDKER, Paul M.Nutrition reviews. 2007, Vol 65, Num 12, issn 0029-6643, S253-S259, 2Conference Paper

Clinical application of C-reactive protein for cardiovascular disease detection and preventionRIDKER, Paul M.Circulation (New York, N.Y.). 2003, Vol 107, Num 3, pp 363-369, issn 0009-7322, 7 p.Article

High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular diseaseRIDKER, Paul M.Circulation (New York, N.Y.). 2001, Vol 103, Num 13, pp 1813-1818, issn 0009-7322Article

Comparison of Characteristics of Future Myocardial Infarctions in Women With Baseline High Versus Baseline Low Levels of High-Sensitivity C-Reactive ProteinBANSAL, Sandeep; RIDKER, Paul M.The American journal of cardiology. 2007, Vol 99, Num 11, pp 1500-1503, issn 0002-9149, 4 p.Article

Proposed cardiovascular risk assessment algorithm using high-sensitivity c-reactive protein and lipid screeningRIFAI, Nader; RIDKER, Paul M.Clinical chemistry (Baltimore, Md.). 2001, Vol 47, Num 1, pp 28-30, issn 0009-9147Article

Should age and time be eliminated from cardiovascular risk prediction models? Rationale for the creation of a New National Risk Detection ProgramRIDKER, Paul M; COOK, Nancy.Circulation (New York, N.Y.). 2005, Vol 111, Num 5, pp 657-658, issn 0009-7322, 2 p.Article

Rosuvastatin for primary prevention in patients with European systematic coronary risk evaluation risk ≥5% or Framingham risk >20%: post hoc analyses of the JUPITER trial requested by European health authoritiesKOENIG, Wolfgang; RIDKER, Paul M.European heart journal. 2011, Vol 32, Num 1, pp 75-83, issn 0195-668X, 9 p.Article

Inflammation and atherothrombosis : From population biology and bench research to clinical practiceLIBBY, Peter; RIDKER, Paul M.Journal of the American College of Cardiology. 2006, Vol 48, Num 9, issn 0735-1097, A33-A46, SUPAArticle

Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005RIDKER, Paul M; TORRES, Jose.JAMA, the journal of the American Medical Association. 2006, Vol 295, Num 19, pp 2270-2274, issn 0098-7484, 5 p.Article

Clinical usefulness of very high and very low levels of c-reactive protein across the full range of framingham Risk scoresRIDKER, Paul M; COOK, Nancy.Circulation (New York, N.Y.). 2004, Vol 109, Num 16, pp 1955-1959, issn 0009-7322, 5 p.Article

Population distributions of C-reactive protein in apparently healthy men and women in the United States: Implication for clinical interpretationRIFAI, Nader; RIDKER, Paul M.Clinical chemistry (Baltimore, Md.). 2003, Vol 49, Num 4, pp 666-669, issn 0009-9147, 4 p.Article

Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: Rationale and design of the JUPITER trialRIDKER, Paul M.Circulation (New York, N.Y.). 2003, Vol 108, Num 19, pp 2292-2297, issn 0009-7322, 6 p.Article

High-sensitivity C-reactive protein : A novel and promising marker of coronary heart diseaseRIFAI, Nader; RIDKER, Paul M.Clinical chemistry (Baltimore, Md.). 2001, Vol 47, Num 3, pp 403-411, issn 0009-9147Article

Current and future directions of cardiovascular risk predictionSMITH, Sidney C.The American journal of cardiology. 2006, Vol 97, Num 2A, issn 0002-9149, 28A-32A, SUPConference Paper

Soluble P-selectin and the risk of future cardiovascular eventsRIDKER, Paul M; BURING, Julie E; RIFAI, Nader et al.Circulation (New York, N.Y.). 2001, Vol 103, Num 4, pp 491-495, issn 0009-7322Article

Novel clinical markers of vascular wall inflammationBLAKE, Gavin J; RIDKER, Paul M.Circulation research. 2001, Vol 89, Num 9, pp 763-771, issn 0009-7330Article

High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin TherapyMORA, Samia; GLYNN, Robert J; RIDKER, Paul M et al.Circulation (New York, N.Y.). 2013, Vol 128, Num 11, pp 1189-1197, issn 0009-7322, 9 p.Article

Progress and challenges in translating the biology of atherosclerosis : CARDIOVASCULAR BIOLOGYLIBBY, Peter; RIDKER, Paul M; HANSSON, Göran K et al.Nature (London). 2011, Vol 473, Num 7347, pp 317-325, issn 0028-0836, 9 p.Article

Myocardial Infarction in a 72-Year-Old Woman with Low LDL-C and Increased hsCRP: Implications for Statin TherapyRIDKER, Paul M.Clinical chemistry (Baltimore, Md.). 2009, Vol 55, Num 2, pp 369-375, issn 0009-9147, 7 p.Article

Novel risk factors for systemic atherosclerosis : A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial diseaseRIDKER, Paul M; STAMPFER, Meir J; RIFAI, Nader et al.JAMA, the journal of the American Medical Association. 2001, Vol 285, Num 19, pp 2481-2485, issn 0098-7484Article

Population-Based Genomewide Genetic Analysis of Common Clinical Chemistry AnalytesCHASMAN, Daniel I; PARE, Guillaume; RIDKER, Paul M et al.Clinical chemistry (Baltimore, Md.). 2009, Vol 55, Num 1, pp 39-51, issn 0009-9147, 13 p.Article

C-Reactive Protein : Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular DiseaseRIDKER, Paul M.Clinical chemistry (Baltimore, Md.). 2009, Vol 55, Num 2, pp 209-215, issn 0009-9147, 7 p.Article

Inflammation, C-Reactive Protein, and AtherothrombosisRIDKER, Paul M; SILVERTOWN, Josh D.Journal of periodontology. 2008, Vol 79, Num 8, pp 1544-1551, issn 0022-3492, 8 p., SUPConference Paper

High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: From concept to clinical practice to clinical benefitRIDKER, Paul M.The American heart journal. 2004, Vol 148, Num 1, pp 19-26, issn 0002-8703, 8 p., SUPConference Paper